文献速递临床试验与 GCP

CADENCE-BZ试验方案更新与统计分析计划:评估苯甲酸钠作为早期精神病辅助治疗疗效的随机临床试验

Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosis.
PubMed 文献 · Trials · 2019-04-08

CADENCE-BZ是一项多中心、平行组、双盲随机对照试验,旨在评估食品防腐剂苯甲酸钠作为早期精神病辅助治疗的临床疗效与安全性。本文在试验完成前更新了方案和统计分析计划,主要变更包括改进统计分析计划以缩减样本量,以及修订次要结局以减少冗余并排除不适当指标。最终参与者正在完成研究,结果将于近期发表。

要点

  • CADENCE-BZ为多中心、平行组、双盲随机对照试验,评估苯甲酸钠辅助治疗早期精神病。
  • 方案更新包括改进统计分析计划以缩减样本量,并修订次要结局以减少冗余。
  • 更新后的统计分析计划在试验完成前发布,以提高数据分析透明度。

核心结论

  • 本文提供CADENCE-BZ试验更新后的统计分析计划,以提高数据分析透明度,最终结果将在近期发表。

研究设计与样本

  • CADENCE-BZ为多中心、平行组、双盲随机对照试验,评估苯甲酸钠作为早期精神病辅助治疗的临床疗效与安全性。
  • 原始方案于2017年发表,本文在试验完成前描述更新方案及统计分析计划。

主要发现

  • 对原始方案做出两项重要变更:改进统计分析计划使样本量得以缩减;修订次要结局以减少冗余并排除不适当的结局指标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: CADENCE-BZ is a multi-centre, parallel-group, double-blind randomized controlled trial designed to examine the clinical efficacy and safety of an accessible food preservative, sodium benzoate, as an add-on treatment for patients with early psychosis. The original study protocol was published in 2017. Here, we describe the updated protocol along with the Statistical Analysis Plan (SAP) for the CADENCE-BZ trial prior to study completion. METHODS AND MATERIALS: Two important changes were made to the original protocol: (1) improvements to our statistical analysis plan permitted a reduction in sample size; and (2) a revision in the secondary outcomes with the intent of reducing redundancy and excluding those measures that were not appropriate as outcomes. CONCLUSIONS: We provide the updated SAP prior to the completion of the study with the intent of increasing the transparency of the data analyses for CADENCE-BZ. The final participants are currently completing the study and the results will be published in the near future. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ( ACTRN12615000187549 ). Registered on 26th February 2015.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lim C, Baker A, Saha S, et al. Protocol update and statistical analysis plan for CADENCE-BZ: a randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosis. Trials. 2019. PMID: 30961658. doi:10.1186/s13063-019-3232-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。